Cartesian Therapeutics, Inc. (RNAC) quarterly income statement — complete revenue, gross profit & net income history
Cartesian Therapeutics, Inc. (RNAC) annual income statement — 12-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 0 | 78K | 947K | 452K | 298K | 1.1M | -759K | 387K | 33.45M | 5.84M | 8.27M | 6.55M | 5.25M | 5.94M | 16.8M | 20.71M | 39.27M | 34M | 29.94M | 24.43M |
| Revenue Growth % | -100% | -92.91% | 224.77% | 16.8% | -99.11% | -81.16% | -109.18% | -94.09% | 537.17% | -1.65% | -50.78% | -68.37% | -86.63% | -82.53% | -43.9% | -15.22% | 99.73% | 207.68% | 150.5% | 425.76% |
| Cost of Goods Sold | 0 | 0 | 0 | 12.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13M | 17.78M | 18.62M | 607K | 539K | 498K | 644K | 0 | 0 |
| COGS % of Revenue | - | - | - | 2831.19% | - | - | - | - | - | - | - | 198.47% | 338.77% | 313.64% | 3.61% | 2.6% | 1.27% | 1.89% | - | - |
| Gross Profit | 0 | 78K | 947K | -12.35M | 298K | 1.1M | -759K | 387K | 33.45M | 5.84M | 8.27M | -6.45M | -12.53M | -12.69M | 16.19M | 20.17M | 38.77M | 33.35M | 29.94M | 24.43M |
| Gross Margin % | - | 100% | 100% | -2731.19% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | -98.47% | -238.77% | -213.64% | 96.39% | 97.4% | 98.73% | 98.11% | 100% | 100% |
| Gross Profit Growth % | -100% | -92.91% | 224.77% | -3289.92% | -99.11% | -81.16% | -109.18% | 106% | 366.86% | 146.03% | -48.94% | -131.98% | -132.32% | -138.03% | -45.93% | -17.42% | 97.2% | 201.86% | 150.5% | 425.76% |
| Operating Expenses | 29.16M | 26.58M | 22.89M | 8.72M | 22.11M | 22.99M | 25.97M | 17.96M | 19.69M | 19.19M | 44.6M | 6.61M | 6.11M | 5.7M | 24.68M | 21.77M | 24.91M | 22.58M | 25.86M | 26.4M |
| OpEx % of Revenue | - | 34073.08% | 2416.68% | 1929.42% | 7419.13% | 2089.91% | -3421.87% | 4641.34% | 58.87% | 328.56% | 539.54% | 100.96% | 116.31% | 95.91% | 146.97% | 105.12% | 63.44% | 66.42% | 86.38% | 108.06% |
| Selling, General & Admin | 8.72M | 7.11M | 8.2M | 7.72M | 7.24M | 8.31M | 7.09M | 6.56M | 7.03M | 9.45M | 22.17M | 6.61M | 6.11M | 5.7M | 5.72M | 5.23M | 5.73M | 4.89M | 5.54M | 5.45M |
| SG&A % of Revenue | - | 9120.51% | 865.58% | 1707.08% | 2429.53% | 755.91% | -933.73% | 1695.61% | 21.01% | 161.82% | 268.17% | 100.96% | 116.31% | 95.91% | 34.04% | 25.26% | 14.6% | 14.39% | 18.51% | 22.29% |
| Research & Development | 20.43M | 19.46M | 14.69M | 13.8M | 14.87M | 14.67M | 11.31M | 11.4M | 12.66M | 9.74M | 22.43M | 13M | 17.78M | 18.62M | 18.97M | 16.54M | 19.18M | 17.69M | 20.32M | 20.95M |
| R&D % of Revenue | - | 24952.56% | 1551.11% | 3053.54% | 4989.6% | 1334% | -1489.59% | 2945.74% | 37.86% | 166.75% | 271.36% | 198.47% | 338.77% | 313.64% | 112.93% | 79.86% | 48.84% | 52.03% | 67.87% | 85.77% |
| Other Operating Expenses | 0 | 0 | 0 | -1000K | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | -1000K | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.16M | -26.5M | -21.94M | -21.07M | -21.81M | -21.89M | -26.73M | -17.57M | 13.76M | -13.35M | -36.33M | -13.06M | -18.64M | -18.38M | -8.5M | -1.6M | 13.86M | 10.77M | 4.08M | -1.97M |
| Operating Margin % | - | -33973.08% | -2316.68% | -4660.62% | -7319.13% | -1989.91% | 3521.87% | -4541.34% | 41.13% | -228.56% | -439.54% | -199.44% | -355.08% | -309.55% | -50.59% | -7.72% | 35.29% | 31.69% | 13.62% | -8.06% |
| Operating Income Growth % | -33.67% | -21.06% | 17.93% | -19.86% | -258.54% | -63.99% | 26.43% | -34.52% | 173.81% | 27.38% | -327.64% | -717.07% | -234.47% | -270.62% | -308.34% | 18.79% | 2966.37% | 250.5% | 151.63% | 85.66% |
| EBITDA | -28.36M | -25.88M | -21.33M | -20.46M | -21.22M | -20.73M | -26.25M | -17.29M | 13.95M | -13.16M | -36.06M | -12.88M | -18.46M | -18.18M | -7.89M | -1.06M | 14.36M | 11.42M | 4.4M | -1.35M |
| EBITDA Margin % | - | -33184.62% | -2252.48% | -4526.55% | -7121.48% | -1884.82% | 3457.84% | -4467.44% | 41.72% | -225.43% | -436.24% | -196.55% | -351.72% | -306.08% | -46.97% | -5.12% | 36.56% | 33.58% | 14.7% | -5.51% |
| EBITDA Growth % | -33.61% | -24.84% | 18.72% | -18.34% | -252.1% | -57.49% | 27.22% | -34.27% | 175.58% | 27.57% | -357.09% | -1114.72% | -228.58% | -259.19% | -279.25% | 21.31% | 1288.59% | 270.94% | 157.5% | 90.1% |
| D&A (Non-Cash Add-back) | 800K | 615K | 608K | 606K | 589K | 1.16M | 486K | 286K | 196K | 183K | 272K | 189K | 176K | 206K | 607K | 539K | 498K | 644K | 323K | 622K |
| EBIT | 16.62M | -39.18M | -101.77M | -35.9M | 15.89M | -17.71M | -9.97M | -24.18M | 13.84M | -56.82M | -196.66M | -13.06M | -18.64M | -18.38M | 6.41M | -7.41M | 9.32M | 29.48M | 13.09M | -1.35M |
| Net Interest Income | 251K | 1.03M | 1.27M | 1.55M | 1.75M | 2.02M | 7.39M | 2.57M | 1.2M | 1.16M | 940K | -1.27M | -752K | -808K | -807K | -802K | -715K | -707K | -711K | -711K |
| Interest Income | 1.1M | 1.03M | 1.27M | 1.55M | 1.75M | 2.02M | 7.39M | 2.57M | 1.2M | 1.16M | 940K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 852K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.27M | 752K | 808K | 807K | 802K | 715K | 707K | 711K | 711K |
| Other Income/Expense | 44.92M | -12.68M | -79.83M | -14.84M | 37.7M | 4.18M | 16.77M | -6.61M | 79K | -43.48M | -160.33M | 4.06M | 7.25M | -3.28M | 14.1M | -6.62M | -5.26M | 18M | 8.3M | -97K |
| Pretax Income | 15.77M | -39.18M | -101.77M | -35.9M | 15.89M | -17.71M | -9.97M | -24.18M | 13.84M | -56.82M | -196.66M | -9M | -11.39M | -21.66M | 5.61M | -8.21M | 8.6M | 28.78M | 12.38M | -2.07M |
| Pretax Margin % | - | -50233.33% | -10746.46% | -7942.92% | 5330.87% | -1610% | 1313.04% | -6248.84% | 41.37% | -973.01% | -2379.12% | -137.41% | -216.94% | -364.82% | 33.37% | -39.66% | 21.9% | 84.64% | 41.34% | -8.46% |
| Income Tax | 0 | 0 | -9.19M | 0 | 0 | 0 | 287K | 0 | 0 | 0 | -19M | 0 | 0 | 0 | -288K | -321K | 0 | 0 | 138K | 15.83M |
| Effective Tax Rate % | 0% | 0% | 9.03% | 0% | 0% | 0% | -2.88% | 0% | 0% | 0% | 9.66% | 0% | 0% | 0% | -5.14% | 3.91% | 0% | 0% | 1.11% | -766.12% |
| Net Income | 13.72M | -39.18M | -92.58M | -35.9M | 15.89M | -17.71M | -10.25M | -24.18M | 13.84M | -56.82M | -177.66M | -9M | -11.39M | -21.66M | 5.89M | -7.89M | 8.6M | 28.78M | 12.24M | -17.89M |
| Net Margin % | - | -50233.33% | -9775.71% | -7942.92% | 5330.87% | -1610% | 1350.86% | -6248.84% | 41.37% | -973.01% | -2149.26% | -137.41% | -216.94% | -364.82% | 35.09% | -38.11% | 21.9% | 84.64% | 40.88% | -73.26% |
| Net Income Growth % | -13.63% | -121.24% | -802.92% | -48.46% | 14.82% | 68.83% | 94.23% | -168.64% | 221.51% | -162.31% | -3114.73% | -14.05% | -232.39% | -175.28% | -51.85% | 55.89% | 88.41% | 217% | 179.24% | -83.92% |
| Net Income (Continuing) | 15.77M | -39.18M | -92.58M | -35.9M | 15.89M | -17.71M | -10.25M | -24.18M | 13.84M | -56.82M | -177.66M | -9M | -11.39M | -21.66M | 5.89M | -7.89M | 8.6M | 28.78M | 12.24M | -17.89M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.46 | -1.46 | -3.46 | -1.38 | 0.60 | -0.68 | -0.07 | -1.13 | 0.54 | -10.50 | -41.56 | -1.74 | -2.23 | -4.24 | 1.16 | -1.55 | 1.74 | 6.77 | 2.96 | -4.66 |
| EPS Growth % | -23.33% | -114.71% | -4914.49% | -22.12% | 11.11% | 93.52% | 99.83% | 35.06% | 124.22% | -147.64% | -3682.76% | -12.26% | -228.16% | -162.63% | -60.81% | 66.74% | 53.98% | 201.65% | 168.84% | -68.23% |
| EPS (Basic) | 0.47 | -1.46 | -3.56 | -1.38 | 0.61 | -0.68 | -0.07 | -1.13 | 0.58 | -10.50 | -41.56 | -1.74 | -2.23 | -4.24 | 1.16 | -1.50 | 1.74 | 6.95 | 3.12 | -4.66 |
| Diluted Shares Outstanding | 29.86M | 26.86M | 25.97M | 26M | 26.45M | 25.9M | 25.91M | 21.47M | 17.79M | 5.41M | 5.17M | 5.16M | 5.11M | 5.11M | 4.83M | 5.09M | 4.95M | 4.14M | 3.84M | 3.84M |
| Basic Shares Outstanding | 29.47M | 26.86M | 25.97M | 26M | 25.98M | 25.9M | 25.91M | 21.47M | 16.72M | 5.41M | 5.17M | 5.16M | 5.11M | 5.11M | 4.83M | 5.09M | 4.95M | 4.14M | 3.84M | 3.84M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |